Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents
Coley, Helen M., Shotton, Christine F., Ajose-Adeogun, Abi, Modjtahedi, Helmout, Thomas, Hilary
Published in Biochemical pharmacology (16.10.2006)
Published in Biochemical pharmacology (16.10.2006)
Get full text
Journal Article